Related Experiment Video
Updated: Jan 13, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Complete blood count parameters as predictors of disease phenotype in pediatric inflammatory bowel disease
Ahsen Donmez Turkmen1, Gizem Tanalı2, Alican Sarısaltık3
1Department of Pediatric Gastroenterology, Hepatology and Nutrition, Marmara University Faculty of Medicine, İstanbul, Türkiye.
Insights
Complete blood count (CBC) indices can predict disease severity in pediatric ulcerative colitis and Crohn's disease. Lower absolute lymphocyte count and lymphocyte-to-monocyte ratio at diagnosis indicate more severe Crohn's disease.
Area of Science:
- Pediatric Gastroenterology
- Hematology
- Inflammatory Bowel Disease Research
Background:
- Complete blood count (CBC) is a routine, cost-effective test.
- Its utility in assessing pediatric inflammatory bowel disease (IBD) phenotypes and activity requires further investigation.
Purpose of the Study:
- To determine if CBC indices can aid in assessing disease phenotype and activity at diagnosis in pediatric IBD.
- To identify CBC parameters that predict disease behavior in Crohn's disease (CD).
Main Methods:
- Compared CBC indices (including NLR, LMR, NMR, ALC) in 120 pediatric IBD patients (UC/CD) and 120 controls.
- Used ROC analysis and Youden Index to find optimal cut-offs for ALC and LMR in predicting CD behavior.
- Employed multivariate logistic regression to assess independent relationships and predict CD behavior.
Main Results:
- IBD patients showed higher leukocyte, platelet, neutrophil, monocyte counts, and NLR than controls.
- CD patients had significantly lower absolute lymphocyte count (ALC) than UC and control groups.
- Decreased ALC and LMR were significant predictors of stricturing, penetrating, and perianal CD.
Conclusions:
- CBC indices at diagnosis can assess UC severity and CD behavior in pediatric IBD.
- These findings highlight the potential role of CBC in predicting IBD disease phenotype.
Objectives:
Complete blood count (CBC) is a simple and cost-effective test performed during routine examination. We investigated whether CBC could assist in the assessment of disease phenotype and disease activity at diagnosis in pediatric inflammatory bowel disease (IBD).
Methods:
We included 120 pediatric patients (73 ulcerative colitis [UC] and 47 Crohn's disease [CD]) and 120 age-matched healthy controls (6-18 years). CBC indices, including neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-monocyte ratio (NMR) measured at onset, were compared between the patient and control groups. Optimal cut-off values for absolute lymphocyte count (ALC) and LMR were determined using the ROC curve analysis and the Youden Index to predict disease behavior in patients with CD. Multivariate logistic regression analysis was used to evaluate the independent relationship between these parameters and to predict disease behavior in CD.
Results:
UC and CD patients demonstrated significantly higher leukocyte, platelet, neutrophil, monocyte counts and NLR compared to controls (p < 0.05). CD patients had significantly lower ALC than UC and control groups (p = 0.008 and p = 0.039, respectively). Patients with moderate- severe UC and pancolitis exhibited significantly decreased Hgb levels, MCV and increased PLT counts (p < 0.05). After adjusting for age and sex at diagnosis, multivariate logistic regression analysis revealed that decreased ALC (< 1.65 ×109/L) and LMR (< 2.54) were significant predictors of CD with stricturing, penetrating disease and perianal involvement (p = 0.049 and p = 0.004, respectively).
Conclusions:
In pediatric IBD, the severity of UC and disease behavior of CD can be assessed using CBC indices at diagnosis. These results demonstrate the potential role of CBC indices in predicting disease phenotype.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

